Through an interactive, visual platform, Accencio delivers actionable intelligence which enables users working across the full drug discovery lifecycle to see, understand, maximize and communicate the full potential of IP, providing a guided pathway to higher returns and increased asset values.
Through their platform they provide a full, multi-level understanding of a targeted IP space. They help customers to identify hard-to-find strategically valuable opportunities and hidden threats, answering key business questions faster and more cost-effectively across R&D, patenting and licensing. Delivered via their proprietary AccencioView™ innovation platform, their interactive tools and related analysis provide vital and novel insight and support.